DigitalTRACE™ dPCR Monitoring
Sensitive Chimerism & Solid Organ Transplant Rejection (dd-cfDNA)
Key Facts
About Jeta Molecular
JETA Molecular is a private, commercial-stage diagnostics company specializing in post-transplant monitoring. Its core technology platform leverages quantitative PCR (qPCR) and digital PCR (dPCR) to deliver highly sensitive chimerism and donor-derived cell-free DNA (dd-cfDNA) tests for hematopoietic stem cell transplant (HSCT) and solid organ transplant patients. With CE-marked products already on the market, JETA is positioned to address a critical unmet need in transplantation medicine by providing tools for early intervention, potentially improving graft survival and patient quality of life. The company benefits from founder expertise and collaborations with key opinion leaders in the field.
View full company profile